237 related articles for article (PubMed ID: 25203145)
1. LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation.
Sharma S; Singh B; Mishra AK; Rathod D; Hazari PP; Chuttani K; Chopra S; Singh PM; Abrar ML; Mittal BR; Singh G
Cancer Biother Radiopharm; 2014 Sep; 29(7):283-8. PubMed ID: 25203145
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
[TBL] [Abstract][Full Text] [Related]
3. Preclinical and Clinical Use of Indigenously Developed
Hazari PP; Yadav SK; Kumar PK; Dhingra V; Rani N; Kumar R; Singh B; Mishra AK
ACS Pharmacol Transl Sci; 2023 Sep; 6(9):1233-1247. PubMed ID: 37705592
[TBL] [Abstract][Full Text] [Related]
4. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement.
Myslivecek M; Koranda P; Kamínek M; Husák V; Hartlová M; Dusková M; Cwiertka K
Nucl Med Rev Cent East Eur; 2004; 7(2):151-5. PubMed ID: 15968602
[TBL] [Abstract][Full Text] [Related]
7. [
Rani N; Singh B; Kumar N; Singh P; Hazari PP; Vyas S; Hooda M; Chitkara A; Shekhawat AS; Gupta SK; Radotra BD; Mishra AK
Cancer Biother Radiopharm; 2021 Sep; 36(7):568-578. PubMed ID: 32644819
[No Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of (99m)Tc-DTPA-bis(His) as a potential probe for tumor imaging with SPECT.
Sinha D; Shukla G; Chuttani K; Chandra H; Mishra AK
Cancer Biother Radiopharm; 2009 Oct; 24(5):615-20. PubMed ID: 19877892
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-methionine scintimammography in the evaluation of breast cancer.
Sharma R; Tripathi M; Panwar P; Chuttani K; Jaimini A; Maitra S; Chopra MK; Sawroop K; Shukla G; Mondal A; Mishra A
Nucl Med Commun; 2009 May; 30(5):338-42. PubMed ID: 19282793
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-L,L-ethylenedicysteine is more effective than technetium-99m diethylenetriamine penta-acetic acid for excluding obstruction in patients with pyelocalicinal dilation.
Lima MC; de Lima ML; Pepe CF; Etchebehere EC; Santos AO; Amorim BJ; Camargo EE; Ferreira U; Palma PC; Ramos CD
Urology; 2010 Aug; 76(2):283-8. PubMed ID: 20206974
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation.
Xia X; Feng H; Li C; Qin C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2016 Jan; 43(1):89-96. PubMed ID: 26466867
[TBL] [Abstract][Full Text] [Related]
12. An improved kit formulation of a dopamine transporter imaging agent: [Tc-99m]TRODAT-1.
Choi SR; Kung MP; Plössl K; Meegalla S; Kung HF
Nucl Med Biol; 1999 May; 26(4):461-6. PubMed ID: 10382851
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-MDM Brain SPECT for the Detection of Recurrent/Remnant Glioma-Comparison With ceMRI and 18F-FLT PET Imaging: Initial Results.
Singh B; Kumar N; Sharma S; Watts A; Hazari PP; Rani N; Vyas S; Anish B; Mishra AK
Clin Nucl Med; 2015 Oct; 40(10):e475-9. PubMed ID: 26204205
[TBL] [Abstract][Full Text] [Related]
15. LAT1 targeted delivery of methionine based imaging probe derived from M(III) metal ions for early diagnosis of proliferating tumours using molecular imaging modalities.
Hazari PP; Prakash S; Meena VK; Jaswal A; Khurana H; Mishra SK; Bhonsle HK; Singh L; Mishra AK
Curr Cancer Drug Targets; 2015; 14(9):817-31. PubMed ID: 25329672
[TBL] [Abstract][Full Text] [Related]
16. Clinical comparison of technetium-99m-N,N-bis(mercaptoacetyl)-2,3-diaminopropanoate with technetium-99m DTPA for renal imaging.
Kuni CC; Klingensmith WC; Fritzberg AR; Spitzer VM; Latteier JL
Clin Nucl Med; 1985 Nov; 10(11):810-3. PubMed ID: 3935354
[TBL] [Abstract][Full Text] [Related]
17. The preparation of 99mTc-DTPA-LSA and its instant lyophilized kit for hepatic receptor imaging.
Yang W; Zhao Z; Fang W; Zhang X
Appl Radiat Isot; 2013 Apr; 74():1-5. PubMed ID: 23314059
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99mTc]-DTPA-DG) as a potential imaging modality for tumors.
Chen Y; Huang ZW; He L; Zheng SL; Li JL; Qin DL
Appl Radiat Isot; 2006 Mar; 64(3):342-7. PubMed ID: 16290170
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-DTPA-amino acids conjugate as specific SPECT pharmaceuticals for tumor imaging.
Sinha D; Shukla G; Tiwari AK; Chaturvedi S; Chuttani K; Chandra H; Mishra AK
Chem Biol Drug Des; 2009 Aug; 74(2):159-64. PubMed ID: 19614681
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Ma Q; Chen B; Gao S; Ji T; Wen Q; Song Y; Zhu L; Xu Z; Liu L
PLoS One; 2014; 9(9):e108349. PubMed ID: 25250628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
